The nation of Zimbabwe has turned down a significant US health deal valued at $367m (£272m) spanning five years over Washington's request for confidential data.
This move came to light after a official document from December was leaked, revealing that President Emmerson Mnangagwa deemed the deal was "skewed".
An official representative later explained that the US was demanding access to genetic material for research and profit while was unwilling to guarantee the benefits from future vaccines.
"We will now turn to the challenging and unfortunate process of winding down our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the United States had provided over $1.9bn as health assistance to Zimbabwe during the past two decades.
A medical body in Zimbabwe has called for further negotiations to secure a agreement suitable to all parties so the nation's critical HIV treatment initiative can be sustained.
Wider Background
Zimbabwe's decision comes after a comparable situation in Kenya, where a court blocked a related health funding agreement after legal challenges were filed about the safety of citizens' medical information.
Since returning to office last year, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
USAID had administered aid for the American government, but Trump argued its spending was "inefficient" and his government was pursuing government-to-government agreements to enhance transparency and responsibility.
Based on statements, Sixteen nations in Africa have so far agreed to these new agreements, constituting more than $18.3bn in committed funds.
Specifics of the Rejected Agreement
The funds for Zimbabwe would have funded "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this collaboration could have provided extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving HIV treatment via American-funded initiatives," the Ambassador said.
However, official spokesman Nick Mangwana maintained the arrangement was "unequal".
"The proposal required Zimbabwe to share its genetic material and health information over an extended period, with no equivalent promise of benefiting from any scientific breakthroughs – like new medicines or tests – that might be developed from that provided information," he stated.
"Put simply, our nation would supply the basic resources for scientific discovery without any certainty that the end products would be accessible to our population if a new disease outbreak emerge."
Sovereignty and Global Health
Mangwana further pointed out that the US's withdrawal from the global health body and its pursuit of one-on-one deals were undermining frameworks already set up through the global health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme created to deal with potential global health emergencies.
"This framework is designed to ensure that when a country contributes its information, the benefits – including medicines and cures – are shared equitably, not commercialised exclusively by those with the capability to create them."
These objections regarding the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We welcome ongoing discussions with our American counterparts on how subsequent co-operation might be structured in a way that honours the independence and dignity of both nations."
Medical Community Reaction
Medical experts said it acknowledged the government's concerns, but suggested that negotiations should continue given that a large portion of the country's Aids initiatives were funded by foreign aid.
"In cases where specific concerns arise, such as those relating to data governance or implementation frameworks, these can frequently be addressed via technical clarification and mutually agreed protections," the group said.
The halted deal highlights the complex tensions between receiving crucial international aid and safeguarding national sovereignty in an increasingly interconnected world.